| Primary |
| Diabetes Mellitus |
47.6% |
| Product Used For Unknown Indication |
19.0% |
| Type 2 Diabetes Mellitus |
14.3% |
| Cardiac Disorder |
9.5% |
| Blood Cholesterol Increased |
4.8% |
| Diabetes Mellitus Management |
4.8% |
|
| Blood Glucose Decreased |
8.0% |
| Blood Glucose Increased |
8.0% |
| Drug Ineffective |
8.0% |
| Skin Discolouration |
8.0% |
| Weight Increased |
8.0% |
| Abdominal Pain |
4.0% |
| Asthenia |
4.0% |
| Completed Suicide |
4.0% |
| Disorientation |
4.0% |
| Dizziness |
4.0% |
| Gastric Disorder |
4.0% |
| Hypoglycaemia |
4.0% |
| Incorrect Dose Administered |
4.0% |
| Medication Error |
4.0% |
| Product Odour Abnormal |
4.0% |
| Pruritus Generalised |
4.0% |
| Renal Failure Acute |
4.0% |
| Renal Failure Chronic |
4.0% |
| Renal Impairment |
4.0% |
| Skin Swelling |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.5% |
| Type 2 Diabetes Mellitus |
13.2% |
| Depression |
10.2% |
| Hiv Infection |
9.6% |
| Hypertension |
8.4% |
| Suicide Attempt |
4.8% |
| Drug Use For Unknown Indication |
3.6% |
| Bacterial Infection |
2.4% |
| Diabetes Mellitus |
2.4% |
| Pain |
2.4% |
| Pulmonary Hypertension |
2.4% |
| Dyslipidaemia |
1.8% |
| Myocardial Ischaemia |
1.8% |
| Colon Cancer |
1.2% |
| Deep Vein Thrombosis |
1.2% |
| Ischaemic Stroke |
1.2% |
| Platelet Aggregation Inhibition |
1.2% |
| Benign Prostatic Hyperplasia |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Calcium Deficiency |
0.6% |
|
| Rhabdomyolysis |
13.3% |
| Drug Interaction |
10.0% |
| Hypoglycaemia |
10.0% |
| Ventricular Arrhythmia |
10.0% |
| Completed Suicide |
6.7% |
| Arterial Thrombosis Limb |
3.3% |
| Blood Uric Acid Abnormal |
3.3% |
| Coronary Artery Disease |
3.3% |
| Diarrhoea |
3.3% |
| Drug Toxicity |
3.3% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Haemoglobin Decreased |
3.3% |
| Hydrocephalus |
3.3% |
| Hyperglycaemia |
3.3% |
| Lactic Acidosis |
3.3% |
| Malaise |
3.3% |
| Metabolic Acidosis |
3.3% |
| Overdose |
3.3% |
| Pancreatitis Chronic |
3.3% |
| Product Odour Abnormal |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.6% |
| Diabetes Mellitus |
15.9% |
| Hypertension |
14.5% |
| Type 2 Diabetes Mellitus |
10.9% |
| Blood Cholesterol Increased |
4.2% |
| Drug Use For Unknown Indication |
3.7% |
| Prophylaxis |
3.7% |
| Depression |
3.3% |
| Hypercholesterolaemia |
2.1% |
| Idiopathic Thrombocytopenic Purpura |
1.9% |
| Cardiac Disorder |
1.8% |
| Dyslipidaemia |
1.8% |
| Arthritis |
1.6% |
| Atrial Fibrillation |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Diabetes Mellitus Inadequate Control |
1.5% |
| Dyspnoea |
1.5% |
| Diabetic Neuropathy |
1.3% |
| Blood Pressure |
1.2% |
| Anxiety |
1.0% |
|
| Myocardial Infarction |
9.8% |
| Pancreatitis |
8.7% |
| Lymphoma |
6.5% |
| Vomiting |
6.5% |
| Cerebrovascular Accident |
5.4% |
| Myocardial Ischaemia |
5.4% |
| Pancytopenia |
5.4% |
| Weight Increased |
5.4% |
| Blood Glucose Increased |
4.3% |
| Drug Ineffective |
4.3% |
| Influenza |
4.3% |
| Oedema Peripheral |
4.3% |
| Platelet Count Increased |
4.3% |
| Product Quality Issue |
4.3% |
| Renal Failure |
4.3% |
| Blood Creatinine Increased |
3.3% |
| Csf Protein Increased |
3.3% |
| Death |
3.3% |
| Flushing |
3.3% |
| Headache |
3.3% |
|
| Interacting |
| Dysphagia |
20.5% |
| Type 2 Diabetes Mellitus |
15.4% |
| Hypertension |
12.8% |
| Pain |
10.3% |
| Bacterial Infection |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Antiplatelet Therapy |
5.1% |
| Deep Vein Thrombosis |
5.1% |
| Ischaemic Stroke |
5.1% |
| Pyrexia |
5.1% |
| Respiratory Tract Infection |
2.6% |
| Urinary Tract Infection |
2.6% |
|
| Drug Interaction |
50.0% |
| Hypoglycaemia |
33.3% |
| Condition Aggravated |
16.7% |
|
